Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.17 Down 0.15(1.33%) May 28, 4:00PM EDT
Add to Portfolio
Prev Close:11.32
Open:11.27
Bid:10.46 x 100
Ask:N/A
1y Target Est:18.09
Beta:4.06
Next Earnings Date: 7-Aug-15BCRX Earnings announcement
Day's Range:11.06 - 11.41
52wk Range:7.85 - 14.62
Volume:460,120
Avg Vol (3m):879,303
Market Cap:810.06M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.33%810.06M
GSKUp 0.40%108.17B
RHHBYUp 1.38%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):48.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.02
Quarterly EPS Est (Jun-15) :-0.27
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback